Literature DB >> 11665871

Preventing and managing drug-induced anaphylaxis.

K L Drain1, G W Volcheck.   

Abstract

Drug-induced anaphylaxis and anaphylactoid reactions have increased in frequency with more widespread use of pharmaceutical agents. Anaphylaxis is a systemic, severe immediate hypersensitivity reaction caused by immunoglobulin (Ig) E-mediated immunological release of mediators of mast cells and basophils. An anaphylactoid reaction is an event similar to anaphylaxis but is not mediated by IgE. The incidence of anaphylactic or anaphylactoid reactions differs amongst classes of medications. Antibacterials are the most usual offenders, and penicillins are the most studied. Other compounds commonly causing reactions include non-steroidal anti-inflammatory drugs, anaesthetics, muscle relaxants, latex and radiocontrast media. Prevention, if possible, is the purpose of detailed patient history taking and physical examination. Simple strategies can be employed to decrease the risk of anaphylaxis. These include consideration of the route of drug administration, identification of patients with known causes of anaphylaxis, and the knowledge that certain medications cross react and are contraindicated in those with known history of anaphylaxis. Tests are available, and include IgE-specific skin tests and radioallergosorbent tests. Penicillins are the only compounds whose antigenic determinants are well documented, it is therefore difficult to determine the negative predictive value of other compounds tested. Oral challenge remains an alternative, though entails risk. Desensitisation procedures, as well as gradual dose escalation protocols, are available and can be implemented based on patient history and diagnostic testing. The management of anaphylaxis is based on control of the airway, breathing and circulation. Treatment consists of epinephrine (adrenaline) and supportive measures. Rapid diagnosis and intervention are important in these life-threatening reactions. After stabilisation, all individuals with a documented history of anaphylaxis require a Medic-Alert bracelet or necklace, and an identification card for their wallet or purse.

Entities:  

Mesh:

Year:  2001        PMID: 11665871     DOI: 10.2165/00002018-200124110-00005

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  39 in total

Review 1.  Anaphylaxis.

Authors:  T P Atkinson; M A Kaliner
Journal:  Med Clin North Am       Date:  1992-07       Impact factor: 5.456

2.  Drug-induced anaphylaxis, convulsions, deafness, and extrapyramidal symptoms.

Authors:  J Porter; H Jick
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

3.  The effect of indication on hypersensitivity reactions associated with zomepirac sodium and other nonsteroidal antiinflammatory drugs.

Authors:  B L Strom; J L Carson; M L Morse; S L West; K A Soper
Journal:  Arthritis Rheum       Date:  1987-10

Review 4.  Common allergic and allergic-like reactions to medications. When the cure becomes the curse.

Authors:  T J Craig; C Mende
Journal:  Postgrad Med       Date:  1999-03       Impact factor: 3.840

5.  Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge.

Authors:  M E Pichichero; D M Pichichero
Journal:  J Pediatr       Date:  1998-01       Impact factor: 4.406

6.  Epinephrine absorption in children with a history of anaphylaxis.

Authors:  F E Simons; J R Roberts; X Gu; K J Simons
Journal:  J Allergy Clin Immunol       Date:  1998-01       Impact factor: 10.793

Review 7.  Adverse reactions to antibiotics. Clues for recognizing, understanding, and avoiding them.

Authors:  R A Gleckman; F Borrego
Journal:  Postgrad Med       Date:  1997-04       Impact factor: 3.840

8.  Elective penicillin skin testing and amoxicillin challenge: effect on outpatient antibiotic use, cost, and clinical outcomes.

Authors:  E Macy
Journal:  J Allergy Clin Immunol       Date:  1998-08       Impact factor: 10.793

Review 9.  Drug-induced severe skin reactions. Incidence, management and prevention.

Authors:  P Wolkenstein; J Revuz
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

10.  Penicillin allergy: clinical experience with a battery of skin-test reagents.

Authors:  G O Solley; G J Gleich; R G Van Dellen
Journal:  J Allergy Clin Immunol       Date:  1982-02       Impact factor: 10.793

View more
  5 in total

1.  Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.

Authors:  Roberto Leone; Anita Conforti; Mauro Venegoni; Domenico Motola; Ugo Moretti; Ilaria Meneghelli; Alfredo Cocci; Giulia Sangiorgi Cellini; Stefania Scotto; Nicola Montanaro; Giampaolo Velo
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Mast cell tryptase and carboxypeptidase A expression in body fluid and gastrointestinal tract associated with drug-related fatal anaphylaxis.

Authors:  Xiang-Jie Guo; Ying-Yuan Wang; Hao-Yue Zhang; Qian-Qian Jin; Cai-Rong Gao
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

3.  Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement.

Authors:  Marek L Kowalski; Ignacio Ansotegui; Werner Aberer; Mona Al-Ahmad; Mubeccel Akdis; Barbara K Ballmer-Weber; Kirsten Beyer; Miguel Blanca; Simon Brown; Chaweewan Bunnag; Arnaldo Capriles Hulett; Mariana Castells; Hiok Hee Chng; Frederic De Blay; Motohiro Ebisawa; Stanley Fineman; David B K Golden; Tari Haahtela; Michael Kaliner; Connie Katelaris; Bee Wah Lee; Joanna Makowska; Ulrich Muller; Joaquim Mullol; John Oppenheimer; Hae-Sim Park; James Parkerson; Giovanni Passalacqua; Ruby Pawankar; Harald Renz; Franziska Rueff; Mario Sanchez-Borges; Joaquin Sastre; Glenis Scadding; Scott Sicherer; Pongsakorn Tantilipikorn; James Tracy; Vera van Kempen; Barbara Bohle; G Walter Canonica; Luis Caraballo; Maximiliano Gomez; Komei Ito; Erika Jensen-Jarolim; Mark Larche; Giovanni Melioli; Lars K Poulsen; Rudolf Valenta; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2016-10-12       Impact factor: 4.084

Review 4.  Epidemiology, Mechanisms, and Diagnosis of Drug-Induced Anaphylaxis.

Authors:  Maria Isabel Montañez; Cristobalina Mayorga; Gador Bogas; Esther Barrionuevo; Ruben Fernandez-Santamaria; Angela Martin-Serrano; Jose Julio Laguna; Maria José Torres; Tahia Diana Fernandez; Inmaculada Doña
Journal:  Front Immunol       Date:  2017-05-29       Impact factor: 7.561

5.  A new strategy of desensitization in mucopolysaccharidosis type II disease treated with idursulfase therapy: A case report and review of the literature.

Authors:  Vincenza Gragnaniello; Silvia Carraro; Laura Rubert; Daniela Gueraldi; Chiara Cazzorla; Pamela Massa; Stefania Zanconato; Alberto B Burlina
Journal:  Mol Genet Metab Rep       Date:  2022-05-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.